Berenberg analyst Kerry Holford lowered the firm’s price target on Eli Lilly (LLY) to $970 from $1,050 and keeps a Buy rating on the shares.

Eli Lilly trims Q4 guidance but maintains optimism with promising drugs like Zepbound for sleep apnea and global launches ...

Eli Lilly's stock dipped due to cutting Q4 sales targets, despite a strong 2024 performance from Mounjaro and Zepbound. Click ...

The updated guidance, which was largely driven by lower-than-anticipated sales of GLP-1 blockbusters Mounjaro and Zepbound, ...

At least 35 historically significant structures have been destroyed by the Eaton and Palisades fires, neither of which have ...

Lululemon is kicking off the new year right and is offering a variety of its best-sellers, including yoga pants, belt bags, ...

Lilly Pulitzer’s Sunshine Sale is packed with discounts on popular dresses, pants, shorts, sweaters, and more fashion finds.

Though we’re well into the winter season, Lilly Pulitzer always finds a way to get us excited for spring and summer. The ...

Put a little sunshine into the cold, gray days of winter with Lilly Pulitzer’s Sunshine Sale. The iconic brand has tons of deals up to 70% off. The sale includes women’s clothing and home goods, all ...

Lilly Pulitzer Sunshine Sale has up to 70% off activewear, dresses, sweaters, accessories, home decor, and more. This rare ...

Oxford Industries' 3Q24 results show worsening sales trends across major brands, with internal factors likely contributing ...